Biotech Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer Genetics
Studies from Institute of Cancer Research provide new data on breast cancer genetics
January 29th, 2007
A new study, "Rare germ line CHEK2 variants identified in breast cancer families encode proteins that show impaired activation," is now available. According to a study from Sutton, the United Kingdom, "Germ line mutations in CHEK2, the gene that encodes the Chk2 serine/threonine kinase activated in response to DNA damage, have been found to confer an increased risk of some cancers. We have previously reported the presence of the common deleterious 1100delC and four rare CHEK2 mutations in inherited breast cancer." "Here, we report that predictions made by bioinformatic analysis on the rare mutations indicate that two of these, delE161 (483-485delAGA) and R117G, are...
Source: Biotech Business Week (2007-01-29)
|
